⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Elevated antipsychotic prescribing (65+)
Risk indicators are statistical patterns, not allegations. Learn more
10,510
Total Claims
$783K
Drug Cost
668
Beneficiaries
$1,172
Cost/Patient
Risk Score Breakdown 6/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+5
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
0%
Cost per patient vs peers
$1,172 vs $1,174 avg
+55%
Brand preference vs peers
13.7% vs 8.9% avg
Brand vs Generic
86% generic
Brand: 1,430 claims · $596K
Generic: 9,003 claims · $182K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Fluticasone/Umeclidin/Vilanter | 136 | $92K |
| Apixaban | 105 | $71K |
| Linaclotide | 97 | $54K |
| Budesonide/Formoterol Fumarate | 68 | $29K |
| Dapagliflozin Propanediol | 28 | $24K |
| Empagliflozin | 22 | $24K |
| Insulin Lispro Protamin/Lispro | 15 | $20K |
| Insulin Lispro Protamin/Lispro | 20 | $19K |
| Rivaroxaban | 16 | $19K |
| Semaglutide | 20 | $18K |
| Tirzepatide | 16 | $18K |
| Dulaglutide | 14 | $13K |
| Fenofibrate | 299 | $9,725 |
| Insulin Glargine,hum.Rec.Anlog | 27 | $9,692 |
| Sacubitril/Valsartan | 13 | $9,358 |
Prescribing Profile
Patient Profile
77
Avg Age
63%
Female
2.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About